This inventor holds 2 USPTO granted patents. Top assignees: Meiji Dairies Corporation, Meiji Milk Products Company, Limited. Active years: 2001-2007.
Company Filing History:
1 out of 41 
1 out of 64 
Years Active: 2001-2007
Title: Gaby Schmitt: Innovator in Neurodegenerative Disease Treatment
Introduction
Gaby Schmitt is a notable inventor based in Strasbourg, France. She has made significant contributions to the field of neurodegenerative disease treatment, holding 2 patents that showcase her innovative approach to medicine.
Latest Patents
One of her latest patents focuses on the use of cyclohexenone long-chain alcohol for treating neurodegenerative diseases. This patent describes a preventive and therapeutic drug that contains a cyclohexenone long-chain alcohol compound. The compound exhibits excellent neurite-extension ability and has an inhibition effect on disorders caused by mutations in the SOD gene. This makes it a valuable active ingredient for treating conditions such as amyotrophic lateral sclerosis. Another patent details the cyclohexenone long-chain alcohol itself, represented by a specific chemical formula.
Career Highlights
Throughout her career, Gaby Schmitt has worked with reputable companies, including Meiji Milk Products Company, Limited and Meiji Dairies Corporation. Her work in these organizations has contributed to her expertise in the field of medicinal chemistry and neurodegenerative disease research.
Collaborations
Gaby has collaborated with notable coworkers, including Yukie Suma and Masashi Yamada. These partnerships have likely enhanced her research and development efforts in creating effective treatments for neurodegenerative diseases.
Conclusion
Gaby Schmitt's innovative work in the treatment of neurodegenerative diseases highlights her significant contributions to medical science. Her patents reflect a commitment to advancing therapeutic options for patients suffering from these challenging conditions.